• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酪氨酸激酶p56lck在缺氧/复氧后通过对IkappaBalpha进行酪氨酸磷酸化来调节细胞运动以及核因子κB介导的尿激酶型纤溶酶原激活剂的分泌。

Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.

作者信息

Mahabeleshwar Ganapati H, Kundu Gopal C

机构信息

National Centre for Cell Science (NCCS), NCCS Complex, Pune, Marahashtra 411 007, India.

出版信息

J Biol Chem. 2003 Dec 26;278(52):52598-612. doi: 10.1074/jbc.M308941200. Epub 2003 Oct 8.

DOI:10.1074/jbc.M308941200
PMID:14534291
Abstract

Nuclear factor kappaB (NFkappaB) plays major role in regulating cellular responses as a result of environmental injuries. The molecular mechanism(s) by which hypoxia/reoxygenation (H/R) regulates p56lck-dependent activation of NFkappaB through tyrosine phosphorylation of IkappaBalpha and modulates the expression of downstream genes that are involved in cell migration in human breast cancer cells are not well defined. In this paper, we investigated the involvement of protein-tyrosine kinase p56lck in the redox-regulated activation of NFkappaB following H/R in highly invasive (MDA-MB-231) and low invasive (MCF-7) breast cancer cells. We demonstrated that H/R induces tyrosine phosphorylation of p56lck, nuclear translocation of NFkappaB, NFkappaB-DNA binding, and transactivation of NFkappaB through tyrosine phosphorylation of IkappaBalpha. Transfection of these cells with wild type Lck but not with mutant Lck F394 followed by H/R induces the tyrosine phosphorylation of inhibitor of nuclear factor kappaB (IkappaBalpha) and transcriptional activation of NFkappaB, and these are inhibited by Lck inhibitors. In vitro kinase assay demonstrated that immunoprecipitated p56lck but not Lyn or Fyn directly phosphorylate IkappaBalpha in presence of H/R. Pervanadate, H2O2, and H/R induce the interaction between Lck and tyrosine-phosphorylated IkappaBalpha, and this interaction is inhibited by Src homology 2 domain inhibitory peptide, suggesting that tyrosine-phosphorylated IkappaBalpha interacts with Src homology 2 domain of Lck. Luciferase reporter gene assay indicated that Lck induces NFkappaB-dependent urokinase type plasminogen activator (uPA) promoter activity in presence of H/R. Furthermore, H/R stimulates the cell motility through secretion of uPA. To our knowledge, this is the first report that p56lck in presence of H/R regulates NFkappaB activation, uPA secretion, and cell motility through tyrosine phosphorylation of IkappaBalpha and further demonstrates an important redox-regulated pathway for NFkappaB activation following H/R injury that is independent of IkappaB kinase/IkappaBalpha-mediated signaling pathways.

摘要

核因子κB(NFκB)在调节因环境损伤引起的细胞反应中起主要作用。缺氧/复氧(H/R)通过IκBα的酪氨酸磷酸化调节p56lck依赖性NFκB激活并调节人乳腺癌细胞中参与细胞迁移的下游基因表达的分子机制尚未明确。在本文中,我们研究了蛋白酪氨酸激酶p56lck在高侵袭性(MDA-MB-231)和低侵袭性(MCF-7)乳腺癌细胞H/R后NFκB的氧化还原调节激活中的作用。我们证明,H/R通过IκBα的酪氨酸磷酸化诱导p56lck的酪氨酸磷酸化、NFκB的核转位、NFκB与DNA的结合以及NFκB的反式激活。用野生型Lck而非突变型Lck F394转染这些细胞后进行H/R处理,可诱导核因子κB抑制因子(IκBα)的酪氨酸磷酸化和NFκB的转录激活,而这些均被Lck抑制剂抑制。体外激酶测定表明,在H/R存在的情况下,免疫沉淀的p56lck而非Lyn或Fyn可直接磷酸化IκBα。过氧钒酸盐、H2O2和H/R诱导Lck与酪氨酸磷酸化的IκBα之间的相互作用,且这种相互作用被Src同源2结构域抑制肽抑制,这表明酪氨酸磷酸化的IκBα与Lck的Src同源2结构域相互作用。荧光素酶报告基因测定表明,在H/R存在的情况下,Lck可诱导NFκB依赖性尿激酶型纤溶酶原激活剂(uPA)启动子活性。此外,H/R通过uPA的分泌刺激细胞运动。据我们所知,这是首次报道在H/R存在的情况下,p56lck通过IκBα的酪氨酸磷酸化调节NFκB激活、uPA分泌和细胞运动,并进一步证明了H/R损伤后NFκB激活的一条重要的氧化还原调节途径,该途径独立于IκB激酶/IκBα介导的信号通路。

相似文献

1
Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.酪氨酸激酶p56lck在缺氧/复氧后通过对IkappaBalpha进行酪氨酸磷酸化来调节细胞运动以及核因子κB介导的尿激酶型纤溶酶原激活剂的分泌。
J Biol Chem. 2003 Dec 26;278(52):52598-612. doi: 10.1074/jbc.M308941200. Epub 2003 Oct 8.
2
Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.酪氨酸激酶、p56lck诱导的细胞运动以及尿激酶型纤溶酶原激活物分泌涉及表皮生长因子受体/细胞外信号调节激酶途径的激活。
J Biol Chem. 2004 Mar 12;279(11):9733-42. doi: 10.1074/jbc.M311400200. Epub 2003 Dec 29.
3
Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.骨桥蛋白通过磷脂酰肌醇3-激酶/蛋白激酶B信号通路刺激乳腺癌细胞的细胞运动性以及核因子κB介导的尿激酶型纤溶酶原激活剂的分泌。
J Biol Chem. 2003 Aug 1;278(31):28593-606. doi: 10.1074/jbc.M303445200. Epub 2003 May 27.
4
Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.骨桥蛋白:其在调节细胞运动及核因子κB介导的尿激酶型纤溶酶原激活剂表达中的作用
IUBMB Life. 2005 Jun;57(6):441-7. doi: 10.1080/15216540500159424.
5
Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis.缺氧调节Syk和Lck之间的相互作用,导致乳腺癌进展和血管生成。
J Biol Chem. 2006 Apr 21;281(16):11322-31. doi: 10.1074/jbc.M512546200. Epub 2006 Feb 10.
6
Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases.酪氨酸磷酸化依赖性激活核因子κB。对p56 LCK和ZAP-70蛋白酪氨酸激酶的需求。
Eur J Biochem. 2001 Mar;268(5):1508-15. doi: 10.1046/j.1432-1327.2001.02028.x.
7
Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.核因子诱导激酶在骨桥蛋白诱导的丝裂原活化蛋白激酶/核因子κB抑制蛋白激酶依赖性核因子κB介导的前基质金属蛋白酶-9激活中起关键作用。
J Biol Chem. 2004 Sep 10;279(37):38921-35. doi: 10.1074/jbc.M404674200. Epub 2004 Jul 7.
8
Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator.磷脂酰肌醇3激酶和核因子κB通过分泌尿激酶型纤溶酶原激活剂来调节侵袭性MDA-MB-231人乳腺癌细胞的运动性。
J Biol Chem. 2002 Feb 1;277(5):3150-7. doi: 10.1074/jbc.M109579200. Epub 2001 Oct 31.
9
c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression.IKKβ的c-Src依赖性酪氨酸磷酸化参与肿瘤坏死因子-α诱导的细胞间黏附分子-1表达。
J Biol Chem. 2003 Mar 14;278(11):9944-52. doi: 10.1074/jbc.m208521200.
10
Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.蛋白激酶C通过激活AP-1和NF-κB上调尿激酶型纤溶酶原激活剂的分泌,从而诱导乳腺癌的迁移。
Biochem Biophys Res Commun. 2002 Jan 11;290(1):552-7. doi: 10.1006/bbrc.2001.6225.

引用本文的文献

1
Decoding the mechanisms behind second primary cancers.解读第二原发性癌症背后的机制。
J Transl Med. 2025 Jan 24;23(1):115. doi: 10.1186/s12967-025-06151-9.
2
Identification of an inflammatory response-related gene prognostic signature and immune microenvironment for cervical cancer.宫颈癌炎症反应相关基因预后特征及免疫微环境的鉴定
Front Mol Biosci. 2024 Jun 6;11:1394902. doi: 10.3389/fmolb.2024.1394902. eCollection 2024.
3
expression profiles and their association with clinical outcomes of breast cancer: a systemic review.
乳腺癌的表达谱及其与临床结局的关联:一项系统综述
Ann Surg Treat Res. 2024 May;106(5):263-273. doi: 10.4174/astr.2024.106.5.263. Epub 2024 Apr 30.
4
Integrative and Comprehensive Pan-Cancer Analysis of Lymphocyte-Specific Protein Tyrosine Kinase in Human Tumors.整合与综合泛癌分析人肿瘤中淋巴细胞特异性蛋白酪氨酸激酶。
Int J Mol Sci. 2022 Nov 13;23(22):13998. doi: 10.3390/ijms232213998.
5
Comprehensively investigating the expression levels and the prognostic role of transforming growth factor beta-induced (TGFBI) in glioblastoma multiforme.全面研究转化生长因子β诱导蛋白(TGFBI)在多形性胶质母细胞瘤中的表达水平及其预后作用。
Transl Cancer Res. 2020 Oct;9(10):6487-6504. doi: 10.21037/tcr-20-2906.
6
New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011-2021) focussing on structure-activity relationship (SAR) and docking insights.淋巴细胞特异性蛋白酪氨酸激酶 (Lck) 抑制剂药物发现的新领域:十年综述 (2011-2021),重点关注结构-活性关系 (SAR) 和对接见解。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1574-1602. doi: 10.1080/14756366.2021.1937143.
7
High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.DEF6 高表达水平预示着透明细胞肾细胞癌患者的预后不良。
Oncol Rep. 2020 Nov;44(5):2056-2066. doi: 10.3892/or.2020.7736. Epub 2020 Aug 18.
8
Beyond TCR Signaling: Emerging Functions of Lck in Cancer and Immunotherapy.超越 TCR 信号:Lck 在癌症和免疫疗法中的新兴功能。
Int J Mol Sci. 2019 Jul 16;20(14):3500. doi: 10.3390/ijms20143500.
9
Inverted formin 2 regulates intracellular trafficking, placentation, and pregnancy outcome.内翻体蛋白 2 调节细胞内运输、胎盘形成和妊娠结局。
Elife. 2018 Jan 8;7:e31150. doi: 10.7554/eLife.31150.
10
The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation.Src 家族激酶 LCK 与致癌性 FLT3/ITD 协同作用促进细胞转化。
Sci Rep. 2017 Oct 23;7(1):13734. doi: 10.1038/s41598-017-14033-4.